| Bruce E Prum Jr, | |
|
2955 Ivy Rd, Charlottesville, VA 22903-9353 | |
| (434) 924-5485 | |
| (434) 244-9436 |
| Full Name | Bruce E Prum Jr |
|---|---|
| Gender | Male |
| Speciality | Ophthalmology |
| Experience | 36 Years |
| Location | 2955 Ivy Rd, Charlottesville, Virginia |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1710056353 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207W00000X | Ophthalmology | 0101052639 (Virginia) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| University Of Virginia Medical Center | Charlottesville, VA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| University Of Virginia Physicians Group | 4880590728 | 1397 |
News Archive
Patients developing AFib after TAVR are at higher risk of death, stroke and heart attack compared to patients who already had AFib prior to the procedure, according to a study today in JACC: Cardiovascular Interventions. The paper is the first nationwide examination of patients who developed AFib for the first time following TAVR.
PolyMedix, Inc., an emerging biotechnology company focused on developing new therapeutic drugs to treat acute cardiovascular disorders and infectious diseases, has successfully completed a Phase 1B/2 dose-ranging clinical study with PMX-60056, a synthetic small-molecule designed to reverse heparin and low molecular weight heparin anticoagulants.
The Prem Rawat Foundation (TPRF) continues to sponsor eye clinics in rural India, most recently by providing US$30,000 to cover the cost of services to nearly 7,000 residents in the states of Jharkhand, Bihar, Uttarakhand and Uttar Pradesh.
In a randomized, Phase III trial led by researchers at The University of Texas MD Anderson Cancer Center, the PARP inhibitor talazoparib extended progression-free survival (PFS) and improved quality-of-life measures over available chemotherapies for patients with metastatic HER2-negative breast cancer and mutations in the BRCA1/2 genes.
› Verified 1 days ago
| Entity Name | University Of Virginia Physicians Group |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1033138250 PECOS PAC ID: 4880590728 Enrollment ID: O20040102000780 |
News Archive
Patients developing AFib after TAVR are at higher risk of death, stroke and heart attack compared to patients who already had AFib prior to the procedure, according to a study today in JACC: Cardiovascular Interventions. The paper is the first nationwide examination of patients who developed AFib for the first time following TAVR.
PolyMedix, Inc., an emerging biotechnology company focused on developing new therapeutic drugs to treat acute cardiovascular disorders and infectious diseases, has successfully completed a Phase 1B/2 dose-ranging clinical study with PMX-60056, a synthetic small-molecule designed to reverse heparin and low molecular weight heparin anticoagulants.
The Prem Rawat Foundation (TPRF) continues to sponsor eye clinics in rural India, most recently by providing US$30,000 to cover the cost of services to nearly 7,000 residents in the states of Jharkhand, Bihar, Uttarakhand and Uttar Pradesh.
In a randomized, Phase III trial led by researchers at The University of Texas MD Anderson Cancer Center, the PARP inhibitor talazoparib extended progression-free survival (PFS) and improved quality-of-life measures over available chemotherapies for patients with metastatic HER2-negative breast cancer and mutations in the BRCA1/2 genes.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Bruce E Prum Jr, Po Box 9007, Charlottesville, VA 22906-9007 Ph: () - | Bruce E Prum Jr, 2955 Ivy Rd, Charlottesville, VA 22903-9353 Ph: (434) 924-5485 |
News Archive
Patients developing AFib after TAVR are at higher risk of death, stroke and heart attack compared to patients who already had AFib prior to the procedure, according to a study today in JACC: Cardiovascular Interventions. The paper is the first nationwide examination of patients who developed AFib for the first time following TAVR.
PolyMedix, Inc., an emerging biotechnology company focused on developing new therapeutic drugs to treat acute cardiovascular disorders and infectious diseases, has successfully completed a Phase 1B/2 dose-ranging clinical study with PMX-60056, a synthetic small-molecule designed to reverse heparin and low molecular weight heparin anticoagulants.
The Prem Rawat Foundation (TPRF) continues to sponsor eye clinics in rural India, most recently by providing US$30,000 to cover the cost of services to nearly 7,000 residents in the states of Jharkhand, Bihar, Uttarakhand and Uttar Pradesh.
In a randomized, Phase III trial led by researchers at The University of Texas MD Anderson Cancer Center, the PARP inhibitor talazoparib extended progression-free survival (PFS) and improved quality-of-life measures over available chemotherapies for patients with metastatic HER2-negative breast cancer and mutations in the BRCA1/2 genes.
› Verified 1 days ago
Ahmed A Ahmed, MD Ophthalmology Medicare: Medicare Enrolled Practice Location: 1300 Jefferson Park Ave, Charlottesville, VA 22903 Phone: 434-924-5485 Fax: 434-244-9436 | |
Dr. Todd J Long, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 620 Berkmar Cir, Charlottesville, VA 22901 Phone: 434-220-3420 Fax: 434-220-3422 | |
Anh-danh Thi Phan, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 1300 Jefferson Park Ave, Charlottesville, VA 22903 Phone: 434-924-5485 Fax: 434-244-9436 | |
Dr. Arthi Venkat, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 1300 Jefferson Park Ave, Charlottesville, VA 22903 Phone: 434-924-5485 Fax: 434-244-9436 | |
James W. Gigantelli Jr., M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 2955 Ivy Rd Ste 240, Charlottesville, VA 22903 Phone: 434-924-5485 Fax: 434-244-9436 | |
Tara Wright Mcgehee, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 1300 Jefferson Park Ave, Charlottesville, VA 22903 Phone: 434-924-5485 Fax: 434-244-9436 | |
Dr. Irfan R Khan, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 1300 Jefferson Park Ave Fl 2, Charlottesville, VA 22903 Phone: 434-924-5485 Fax: 434-924-5180 |